The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

Research Pinpoints Weakness in Lung Cancer's Defenses Feb. 10, 2025 — Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in ...

To fight off viral and bacterial invaders, immune cells known as lymphocytes generate antibodies that specifically recognize ...

the drug has generate promising results in advanced non-small cell lung cancer (NSCLC). Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response ...

"Most patients treated for small cell lung cancer experience rapid progression of disease and there is a high unmet need in the advanced setting," he added. "These interim results from the first ...

Stage 3 lung cancer is considered locally advanced with spread in the region near the site. Survival rates for stage 3 non-small cell lung cancer (NSCLC) range from as high as 36% to as low as 13%, ...

This page shows an A-Z list of postgraduate taught courses starting in the academic year 2025-2026. You can also search all available courses.

aDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA bDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, ...

Bringing together an elite cadre of clinicians, investigators, and educators in one of the world's top medical schools.